N-Dimensional Reduction Algorithm for Learning from Demonstration Path Planning. [PDF]
Manrique-Cordoba J +2 more
europepmc +1 more source
ABSTRACT Objectives Retrograde trans‐synaptic degeneration (rTSD) from posterior visual pathway lesions in multiple sclerosis (MS) is characterized by hemi‐macular ganglion cell‐inner plexiform layer (GCIPL) thinning and contralateral visual field loss.
Abdul Jaber Tayem +17 more
wiley +1 more source
Dimensional reduction and adaptation-development-evolution relation in evolved biological systems. [PDF]
Kaneko K.
europepmc +1 more source
ABSTRACT Objective To explore how cerebral hypoxia and Normal‐Appearing White Matter (NAWM) integrity affect MS lesion burden and clinical course. Methods Seventy‐nine MS patients, including 13 clinically isolated syndrome (CIS) patients and 66 relapsing–remitting multiple sclerosis (RRMS) patients, and 44 healthy controls (HCs) were recruited from ...
Xinli Wang +8 more
wiley +1 more source
An interpretable dimensional reduction technique with an explainable model for detecting attacks in Internet of Medical Things devices. [PDF]
Lipsa S, Dash RK, Ivković N.
europepmc +1 more source
Dimensional reduction of the small-bandgap double perovskite Cs2AgTlBr6. [PDF]
Connor BA +3 more
europepmc +1 more source
A Depolarizing Leak in Sodium Bicarbonate Cotransporter NBCe1 Causes Brain Edema
ABSTRACT Objectives SLC4A4 encodes electrogenic sodium bicarbonate cotransporter NBCe1, prominently expressed in kidney and brain. Recessive loss‐of‐function variants in SLC4A4 cause proximal renal tubular acidosis, no brain edema. In the brain, NBCe1 is expressed by astrocytes, where it regulates pH and mediates astrocyte volume changes.
Quinty Bisseling +16 more
wiley +1 more source
Amino Acid-Driven Dimensional Reduction of CsPbBr3 Nanocrystals. [PDF]
Agarwal N, Agarwal D, Debnath T.
europepmc +1 more source
CSF Monoamine Metabolites and Cognitive Trajectory in Early Parkinson's Disease
ABSTRACT Background Imaging and postmortem studies indicate that abnormalities in monoaminergic neurotransmission contribute to cognitive impairment in Parkinson's disease (PD). However, it remains uncertain if cerebrospinal fluid (CSF) monoamine metabolites can serve as biomarkers of cognitive decline in early PD.
Jing‐Yu Shao +7 more
wiley +1 more source
Correction to: Dimensional reduction and adaptation-development-evolution relation in evolved biological systems. [PDF]
Kaneko K.
europepmc +1 more source

